Hyderabad: The genetic testing company GeneStore with operations spread across India, the UAE, France and Uruguay, plans to launch a biotechnology research initiative, showcasing research talent and development in public institutions for biotechnology research institutes in India and enabling them to start their own biotech startups. .
Anubhav Anusha, founder and global chief operating officer, GeneStore, told Telangana Today: “I strongly believe in Indian R&D talent. We have seen Indian talent go to France and train R&D professionals there. To create biotechnological research incubators in India, it is important to further strengthen the capabilities here. The only reason the US pharmaceutical and biotechnology industry is so advanced is that technology is being transferred from public institutions to the private sector. ”
‘We plan to launch the greenhouse program, which provides access to research talents in the Indian Council for Medical Research (ICMR) and non-ICMR funded institutes across India to explore technologies and build existing infrastructure to build a profitable business build or develop their technology platforms. , “he added.
The company will launch the incubator initiative after launching its new production facility in Gurugram in mid-April, allowing research institutes to set up private businesses, and GeneStore will guide them on how to build a profitable business and how to generate funding for them. activities.
GeneStore also wants to help companies in Europe in the private sector, which is currently engaged in research, where the partnership of the company can improve their capabilities and make their business profitable. The company acquired a cell biology research business near Marseille, France, in 2019.
Growth opportunities
The company that makes RT-PCR test kits in India and France Covid-19 develops test kits for HIV, hepatitis, tuberculosis and other infectious diseases.
‘We believe the future is PCR-free, which means that technology is transitioning from RT-PCR to a platform that uses molecular enzymes but does not require PCR to deliver results. We plan to launch the entire future product portfolio based on this belief. In the next 2-3 months, we will have at least 100 test kits in our portfolio to supply in India as well as worldwide, addressing infectious diseases, ”he added.
In the field of biotechnology product development, GeneStore develops mRNA vaccines to combat infectious diseases and genetic disorders. The company will invest more than 80 million in India in expanding its presence in laboratories for genetic testing in India, as well as producing and expanding research.
Anusha said the company foresees that India will become the most important manufacturing and export hub for molecular diagnostic kits worldwide. It strengthens its team to explore organic and inorganic growth opportunities. Of the 250 people working for the company, 70 per cent are in India.
Source: Telangana Today